Learn how two studies from Denmark expand upon earlier U.S. work that first linked the medication with the eye disease.
The effects that a pause may have on your body may depend on why you're taking the medication in the first place.
Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
Authorized generics are the exact copies of branded drugs, sold by another company with the branded drug manufacturer’s ...
The condition is more common in people who are overweight or obese. Similar to semaglutide treatments like Ozempic and Wegovy ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
Semaglutide, the active ingredient in Ozempic and Wegovy, has been linked to a condition that can cause permanent vision loss ...
Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...
The experimental drug puts semaglutide, the ingredient in Ozempic and the weight-loss drug Wegovy, together with a medicine ...
Novo Nordisk has its weekly diabetes hopeful semaglutide filed in five key markets, after submitting a dossier in Japan. Novo has just filed semaglutide, a new glucagon-like peptide (GLP-1 ...
Tirzepatide treatment led to a 47% greater relative reduction in weight compared with semaglutide. Topline results were announced from a phase 3b clinical trial comparing tirzepatide with ...